EVUSHELD™ long-acting antibody combination retains neutralizing activity against Omicron variants including BA.2 in new independent studies - read this article along with other careers information, tips and advice on BioSpace
In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants at least in rodents but that many antibody-based therapies may not be effective against it.
In two recent studies, researchers at Washington University School of Medicine found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants at least in rodents but that many antibody-based therapies may not be effective against it.